Biomarkers in long COVID-19: A systematic review

The study aimed to systematically evaluate blood biomarkers that may serve as indicators or therapeutic targets for long COVID, also known as post-acute sequelae of COVID-19. This condition refers to a range of long-term symptoms experienced by individuals who continue to suffer from symptoms for one or more months following SARS-CoV-2 infection. Key Findings: Conclusion: The findings underscore the importance of further investigations to identify a core set of blood biomarkers for diagnosing and managing long COVID patients in clinical practice. This research contributes to the growing understanding of the biological underpinnings of long COVID and its potential diagnostic and…